Bio-Techne Corporation
Bio-Techne Corporation (TECH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · TECH · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
4
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Bio-Techne Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
TECH insider buying and selling by quarter
TECH insider selling · TECH insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · TECH ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
TECH executive sell shares · TECH board member insider trading · TECH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 2, 2026 | Crouse Steven C. President - Diag & Spatial Bi | Option | 600 | — | Form 4 |
| Jun 2, 2026 | Crouse Steven C. President - Diag & Spatial Bi | Other | 216 | $11K | Form 4 |
| May 8, 2026 | Herr Amy E. Director | Option | 6,636 | $316K | Form 4 |
| May 8, 2026 | Herr Amy E. Director | Sale | 6,636 | $320K | Form 4 |
| May 5, 2026 | Hippel James CFO | Option | 62,000 | $2.95M⚡ | Form 4 |
| May 5, 2026 | Hippel James CFO | Other | 56,955 | $3.23M⚡ | Form 4 |
| May 5, 2026 | Bohnen Shane SVP - General Counsel | Option | 8,400 | $400K | Form 4 |
| May 5, 2026 | Bohnen Shane SVP - General Counsel | Other | 7,055 | $400K | Form 4 |
| May 5, 2026 | Kelderman Kim CEO · Director | Option | 26,692 | $1.27M⚡ | Form 4 |
| May 5, 2026 | Kelderman Kim CEO · Director | Other | 23,951 | $1.36M⚡ | Form 4 |
| May 1, 2026 | Crouse Steven C. President - Diag & Spatial Bi | Option | 794 | — | Form 4 |
| May 1, 2026 | Crouse Steven C. President - Diag & Spatial Bi | Other | 311 | $17K | Form 4 |
| Apr 22, 2026 | Kelderman Kim CEO · Director | Option | 11,344 | — | Form 4 |
| Apr 22, 2026 | Kelderman Kim CEO · Director | Other | 1,363 | $80K | Form 4 |
| Apr 22, 2026 | Hippel James CFO | Option | 62,000 | — | Form 4 |
| Apr 22, 2026 | Hippel James CFO | Other | 56,097 | $3.29M⚡ | Form 4 |
| Apr 14, 2026 | Kelderman Kim CEO · Director | Option | 36,500 | — | Form 4 |
| Apr 14, 2026 | Kelderman Kim CEO · Director | Other | 32,088 | $1.88M⚡ | Form 4 |
| Apr 3, 2026 | Bohnen Shane SVP - General Counsel | Option | 2,259 | — | Form 4 |
| Apr 3, 2026 | Bohnen Shane SVP - General Counsel | Other | 740 | $39K | Form 4 |
| Feb 17, 2026 | Herr Amy E. Director | Sale | 1,976 | $117K | Form 4 |
| Feb 3, 2026 | Herr Amy E. Director | Option | 38 | — | Form 4 |
| Feb 3, 2026 | Herr Amy E. Director | Other | 16 | $1K | Form 4 |
| Feb 1, 2026 | McManus Matthew President - Diag & Spatial Bio | Option | 4,621 | — | Form 4 |
| Feb 1, 2026 | McManus Matthew President - Diag & Spatial Bio | Other | 1,665 | $107K | Form 4 |
Crouse Steven C.
President - Diag & Spatial Bi
Date
Jun 2
Shares
600
Price
—
Value
—
Crouse Steven C.
President - Diag & Spatial Bi
Date
Jun 2
Shares
216
Price
$49.77
Value
$11K
Bohnen Shane
SVP - General Counsel
Date
May 5
Shares
8,400
Price
$47.60
Value
$400K
Bohnen Shane
SVP - General Counsel
Date
May 5
Shares
7,055
Price
$56.68
Value
$400K
Kelderman Kim
CEO · Director
Date
May 5
Shares
26,692
Price
$47.60
Value
$1.27M ⚡
Crouse Steven C.
President - Diag & Spatial Bi
Date
May 1
Shares
794
Price
—
Value
—
Crouse Steven C.
President - Diag & Spatial Bi
Date
May 1
Shares
311
Price
$55.02
Value
$17K
Kelderman Kim
CEO · Director
Date
Apr 14
Shares
32,088
Price
$58.66
Value
$1.88M ⚡
McManus Matthew
President - Diag & Spatial Bio
Date
Feb 1
Shares
4,621
Price
—
Value
—
McManus Matthew
President - Diag & Spatial Bio
Date
Feb 1
Shares
1,665
Price
$64.09
Value
$107K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About TECH insider trading
TECH insider trades
Bio-Techne Corporation (TECH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Hippel James (CFO), Kelderman Kim (CEO · Director), Herr Amy E. (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. TECH insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Bio-Techne Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
TECH insider trading · 5 questionsThe insiders of Bio-Techne Corporation (TECH) include executives and directors such as Hippel James (CFO), Kelderman Kim (CEO · Director), Herr Amy E. (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026